AllianceBernstein (NYSE:AB) was downgraded at TD Cowen after Equitable Holdings (NYSE:EQH) announced a tender offer for up to ...
TD Cowen initiated coverage of Maze Therapeutics (MAZE) with a Buy rating and no price target The company’s MZE829, and oral APOL1 inhibitor, ...
The report raised fears about the sustainability of AI infrastructure growth. That could mean less demand for Nvidia's chips.
Eli Lilly (LLY) and Novo Nordisk (NVO) to dominate as TD Cowen lifts 2030 sales forecast for GLP-1 class of obesity/ diabetes ...
TD Cowen analyst Andrew Kligerman maintained a Buy rating on Abacus Life (ABL – Research Report) today and set a price target of $14.00. The ...
TD Cowen analyst Doug Creutz raised the firm’s price target on Live Nation (LYV) to $166 from $145 and keeps a Buy rating on ...
Cowen notes that Microsoft is citing construction delays and lack of access to power as excuses for trying to get out of its ...